- Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
- Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers
- Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development
- Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price
Key statistics
On Friday, Tevogen Bio Holdings Inc (TVGN:NMQ) closed at 1.00, 24.53% above the 52 week low of 0.803 set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.20 |
---|---|
High | 1.20 |
Low | 0.93 |
Bid | 0.94 |
Offer | 1.00 |
Previous close | 0.85 |
Average volume | 1.22m |
---|---|
Shares outstanding | 154.75m |
Free float | 1.65m |
P/E (TTM) | -- |
Market cap | 154.75m USD |
EPS (TTM) | -0.4043 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.
More ▼